HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia, M. Articles by Rochefort, H. Search for Related Content PubMed PubMed Citation Articles by Garcia, M. Articles by Rochefort, H.

Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis

Université de Montpellier I and Unité Hormones et Cancer, Montpellier, France

Key Words. Cathepsin D • Breast cancer • Metastasis • Prognosis • Phagocytosis • Growth inhibitors

Dr. Henri Rochefort, Université de Montpellier I and Unité Hormones et Cancer (U 148) INSERM, 60, rue de Navacelles, 34090 Montpellier, France.

Cathepsin D (cath-D) is an aspartyl lysosomal protease expressed in all tissues. Most metastatic breast cancer cell lines, unlike normal cells, secrete high levels of pro-cath-D. This abnormal secretion is due to both overexpression of the cath-D gene and to an altered processing of the precursor protein. Cath-D gene transcription is increased by estrogen and growth factors in estrogen-receptor-positive breast cancer cells and by an unknown mechanism in estrogen-receptor-negative cells. A large number of independent clinical studies associated high cath-D concentrations in the cytosol of primary breast cancers with increased risk of subsequent metastasis. The amino acid sequence of cath-D analyzed in two breast cancer cell lines is normal, but glycosylation appears to be different with more acidic isoforms. To assess the potential role of this protease in cancer metastasis, we transfected a human cDNA cath-D expression vector in 3Y1-Ad12 embryonic rat tumorigenic cells which did not secrete the proenzyme. A moderate overexpression of human cath-D was sufficient to increase the metastatic potential of these cells in nude mice. The mechanism of cath-D-induced metastasis seems to require maturation of the proenzyme, in endosomes and in large acidic compartments identified as phagosomes. Rather than increase cancer cell escape from the primary tumor through basement membrane degradation as proposed for neutral porteinases, cath-D appears to facilitate cell growth at distant sites. The mechanism of this indirect mitogenic effect is discussed from results obtained in different models. Different cath-D substrates (growth inhibitors, precursors of growth factors, etc.) are proposed to mediate this activity.

This article has been cited by other articles:

				Y. Choi, R. Weissleder, and C.-H. Tung Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res., July 15, 2006; 66(14): 7225 - 7229. [Abstract] [Full Text] [PDF]

				R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935. [Abstract] [Full Text] [PDF]

				E. A. Stronach, G. C. Sellar, C. Blenkiron, G. J. Rabiasz, K. J. Taylor, E. P. Miller, C. E. Massie, A. Al-Nafussi, J. F. Smyth, D. J. Porteous, et al. Identification of Clinically Relevant Genes on Chromosome 11 in a Functional Model of Ovarian Cancer Tumor Suppression Cancer Res., December 15, 2003; 63(24): 8648 - 8655. [Abstract] [Full Text] [PDF]

				C.-H. Tung, U. Mahmood, S. Bredow, and R. Weissleder In Vivo Imaging of Proteolytic Enzyme Activity Using a Novel Molecular Reporter Cancer Res., September 1, 2000; 60(17): 4953 - 4958. [Abstract] [Full Text]

				T. T. Lah, A. Blejec, J. Kos, E. Gorodetsky, R. Somers, and I. Daskal Cathepsin B, a Prognostic Indicator in Lymph Node-negative Breast Carcinoma Patients: Comparison with Cathepsin D, Cathepsin L, and Other Clinical Indicators Clin. Cancer Res., February 1, 2000; 6(2): 578 - 584. [Abstract] [Full Text]

				U. Mahmood, C.-H. Tung, A. Bogdanov Jr, and R. Weissleder Near-Infrared Optical Imaging of Protease Activity for Tumor Detection Radiology, December 1, 1999; 213(3): 866 - 870. [Abstract] [Full Text]

				S. Khurana, K. Liby, A. R. Buckley, and N. Ben-Jonathan Proteolysis of Human Prolactin: Resistance to Cathepsin D and Formation of a Nonangiostatic, C-Terminal 16K Fragment by Thrombin Endocrinology, September 1, 1999; 140(9): 4127 - 4132. [Abstract] [Full Text]

				A. Scorilas, J. Yotis, C. Pateras, T. Trangas, and M. Talieri Predictive Value of c-erbB-2 and Cathepsin-D for Greek Breast Cancer Patients Using Univariate and Multivariate Analysis Clin. Cancer Res., April 1, 1999; 5(4): 815 - 821. [Abstract] [Full Text] [PDF]

				T. Strojnik, J. Kos, B. Zidanik, R. Golouh, and T. Lah Cathepsin B Immunohistochemical Staining in Tumor and Endothelial Cells Is a New Prognostic Factor for Survival in Patients with Brain Tumors Clin. Cancer Res., March 1, 1999; 5(3): 559 - 567. [Abstract] [Full Text] [PDF]

				W. Xing and T. K. Archer Upstream Stimulatory Factors Mediate Estrogen Receptor Activation of the Cathepsin D Promoter Mol. Endocrinol., September 1, 1998; 12(9): 1310 - 1321. [Abstract] [Full Text]